Down-regulated genes in E2-treated CD133+/CD34+ cells also included the newly characterized tumor suppressor genes DOCK4, a member of the CDM gene family, and SPARCL1, which encodes an extracellular matrix-associated glycoprotein. This evidence concerns the gene PROM1 and neoplasm.